Biomerica, Inc.
BMRA · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,973 | -$5,978 | -$7,140 | -$4,531 |
| Dep. & Amort. | $400 | $374 | $351 | $595 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $460 | $837 | $1,185 | $1,260 |
| Change in WC | $268 | -$625 | -$38 | $2,915 |
| Other Non-Cash | $4 | $31 | $168 | -$719 |
| Operating Cash Flow | -$3,841 | -$5,361 | -$5,474 | -$481 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$37 | -$51 | -$78 | -$170 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$64 | $0 | $0 |
| Investing Cash Flow | -$37 | -$115 | -$78 | -$170 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,143 | -$81 | $10,014 | $2,402 |
| Stock Repurch. | $0 | $0 | -$705 | -$85 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$32 | $0 | $81 | $78 |
| Financing Cash Flow | $2,111 | -$81 | $9,390 | $2,395 |
| Forex Effect | -$3 | $8 | -$36 | -$26 |
| Net Chg. in Cash | -$1,770 | -$5,549 | $3,802 | $1,718 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,170 | $9,719 | $5,917 | $4,199 |
| End Cash | $2,400 | $4,170 | $9,719 | $5,917 |
| Free Cash Flow | -$3,878 | -$5,476 | -$5,552 | -$651 |